1. Nosadini R, Manzato E, Solini A, Fioretto P, Brocco E, Zambon S, Morocutti A, Sambataro M, Velussi M, Cipollina MR, Crepaldi G. Peripheral, rather than hepatic, insulin resistance and atherogenic lipoprotein phenotype predict cardiovascular complications in NIDDM. EurJ Clin Invest 1994;24:258–266.
2. Lindahl B, Asplund K, Hallmans G. High serum insulin, insulin resistance and their associations with cardiovascular risk factors. The Northern Sweden Monica population study. J Int Med 1993;234:263–270.
3. Page MM, Smith RBW, Watkins PJ. Cardiovascular effects of insulin. Br J Pharmacol 1976;1:430–432.
4. Liang C-S, Doherty JU, Faillace R, Maekawa K, Arnold S, Gavras H, Hood WB. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J Clin Invest 1982;69:1321–1336.
5. Baron AD, Brechtel G. Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol (Endocrinol Metab 28) 1993;265:E61–E67.